Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing emergency coronary intervention

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 1849-1855

  Naruse, Hiroyuki ^a   Ishii, Junnichi ^a   Hashimoto, Tousei ^a   Kawai, Tomoko ^a   Hattori, Kousuke ^a   Okumura, Masanori ^a   Motoyama, Sadako ^a   Matsui, Shigeru ^a   Tanaka, Ikuko ^a   Izawa, Hideo ^b   Nomura, Masanori ^b   Ozaki, Yukio ^a  

^a FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Acute coronary syndrome; Contrast induced acute kidney injury; Glucose; Maximum allowable contrast dose; Percutaneous coronary intervention

Indexed keywords

CONTRAST MEDIUM; CREATININE; GLUCOSE;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; CONTRAST INDUCED NEPHROPATHY; CORONARY CARE UNIT; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERGLYCEMIA; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RESUSCITATION; RISK FACTOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; LENGTH OF STAY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CONTRAST MEDIA; CREATININE; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864387172     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1248     Document Type: Article

References (37)

1. Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrastinduced nephropathy after intravascular angiography: A systematic review and meta-analysis. BMC Med 2004; 2: 38.
2. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006; 98: 14K-20K.
3. Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, et al. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv 2010; 3: 346-350.
4. McCullough PA, Wolyn R, Rocher L, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-375.
5. Marenzi G, Lauri G, Assanelli E, Campodonico J, Metrio MD, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780-1785.
6. Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isono T, Manabe K, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 2010; 105: 624-628.
7. Cigarroa RG, Lange L, Williams RH, Hillis D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649-652.
8. Freeman RV, O'Donnell M, Share D, Meenge WL, Kline-Rogers E, Clark VL, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073.
9. Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, Metrio M, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009; 150: 170-177.
10. Deedwania P, Kosiborod CM, Barret E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: A scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610-1619.
11. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: Implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-3086.
12. Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989; 64: 885-888.
13. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355: 773-778.
14. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: Results from the CARDINAL study. Eur Heart J 2006; 27: 1289-1297.
15. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper-and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005; 26: 1255-1261.
16. Kadri Z, Danchin N, Vaur L, Cottin Y, Gueret P, Zeller M, et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: Results from the nationwide French USIC 2000 study. Heart 2006; 92: 910-915.
17. Stolker JM, MuCullough PA, Rao S, Inzucchi SE, Spertus JA, Maddox TM, et al. Pre-procedural glucose levels and the risk for contrastinduced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol 2010; 55: 1433-1440.
18. Marenzi G, Metrio MD, Rubino M, Lauri G, Cavallero A, Assanelli E, et al. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Am Heart J 2010; 160: 1170-1177.
19. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Prediction of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353.
20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
21. Mueller C, Buerkle G, Buettner H, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336.
22. Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98: 59K-77K.
23. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29-C34.
24. Vanhorebeek I, Gunst J, Ellger B, Boussemaere M, Lerut E, Debaveye Y, et al. Hyperglycemic kidney damage in an animal model of prolonged critical illness. Kidney Int 2009; 76: 512-520.
25. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, et al. Hyperglycemia rapidly suppresses flow-mediated endotheliumdependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34: 146-154.
26. Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis EA, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 2001; 38: 71-76.
27. Gresele P, Guglielmini G, DeAngelis M, Ciferri S, Ciofetta M, Falcinelli E, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013-1020.
28. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996; 45: 954-959.
29. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072.
30. Guha M, Bai W, Nadler JL, Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 2000; 275: 17728-17739.
31. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973.
32. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: The Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004; 27: 354-361.
33. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: A 20-year follow-up study. Diabetes Care 2006; 29: 1585-1590.
34. Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol 2003; 92: 368-372.
35. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome. Circ J 2010; 74: 1165-1174.
36. Kume N, Mitsuoka H, Hayashida K, Tanaka M, Kita T. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome. Circ J 2010; 74: 1399-1404.
37. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Is admission hyperglycemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 2006; 27: 2413-2419.